Field testing expansion DetectaChem’s portfolio includes mobile field drug test kits, a Raman spectrometer for rapid on-site drug/narcotics identification, and an explosive/drug detection device. This combination presents upsell opportunities to law enforcement, military units, and first responders who require portable, integrated testing solutions with digital reporting.

Integrated mobile reporting The free mobile app that captures test results and generates customizable reports with date, time, officer badge, and GPS data enables a compelling value proposition for departments seeking digital case management and traceability, suggesting sales potential with procurement teams emphasizing interoperability and workflow efficiency.

Rapid tech adoption Products like Apex R7 and SEEKER Pro highlight fast, user-friendly, rugged detection technology at competitive price points. Target agencies prioritizing quick deployment, reduced calibration downtime, and cost-conscious budgeting are likely early adopters for onboarding new field teams.

FDA/US government alignment Historical milestones such as FDA Emergency Use Authorisation for MD-Bio COVID testing and DoD/ Homeland Security usage imply strong credibility with federal and state agencies. There is potential for expanding partnerships, sole-source opportunities, or multi-year contracts for portables and response kits.

Diversified threat portfolio DetectaChem covers drugs, explosives, and infectious disease detection with multiple product lines and recent program launches (COVID K9 screening, fentanyl test strips). This breadth enables cross-sell within defense, public health, and law enforcement segments, especially in agencies facing multi-threat readiness requirements.